| Bioactivity | Antibacterial agent 219 (Compound 2/75c) exhibits antibacterial activity by targeting cell wall biosynthesis. Antibacterial agent 219 inhibits methicillin-resistant Staphylococcus aureus (MRSA) strains (MIC=0.5-32 µg/mL), Enterococcus faecium (MIC=2 µg/mL) and S. aureus (MIC=2 µg/mL)[1][2]. |
| CAS | 1649473-91-5 |
| Formula | C22H14FN3O2 |
| Molar Mass | 371.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ceballos S, et al., Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria. Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00453-18. [2]. Chang M, et al., Non-beta lactam antibiotics. WO2016049586. |
Antibacterial agent 219
CAS: 1649473-91-5 F: C22H14FN3O2 W: 371.36
Antibacterial agent 219 (Compound 2/75c) exhibits antibacterial activity by targeting cell wall biosynthesis. Antibacter
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.